Live Breaking News & Updates on Professor Nicholas Lintzeris

Stay updated with breaking news from Professor nicholas lintzeris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Research Shows Medical Cannabis Treating 2.7 Percent Of Population

Research Shows Medical Cannabis Treating 2.7 Percent Of Population
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

New South Wales , Iain Mcgregor , Nicholas Lintzeris , National Drug Strategy Household , Lambert Initiative , Cannabis As Medicine , Therapeutic Goods Administration , Lambert Initiative For Cannabinoid Therapeutics , University Of Sydney , Australian Institute Of Health , Professor Iain Mcgregor , Academic Director , Cannabinoid Therapeutics , National Drug Strategy Household Survey , Australian Institute , Medicine Survey , Harm Reduction Journal , Professor Nicholas Lintzeris ,

Australian Medical Cannabis Survey: Call For Participants

Researchers from University of Sydney's Lambert Initiative for Cannabinoid Therapeutics have launched a new Cannabis as Medicine survey. ....

Nicholas Lintzeris , Iain Mcgregor , Lambert Initiative , Cannabinoid Therapeutics , Professor Nicholas Lintzeris ,

Medicinal cannabis driving ban under review in Queensland

The Queensland government is set to review its drug driving laws that could allow drivers with a prescription back onto the road. ....

New South Wales , Nicholas Lintzeris , Andrew Mahon , University Of Sydney , Main Roads , Professor Nicholas Lintzeris ,

Legal use of medicinal cannabis on rise

Legal use of medicinal cannabis on rise
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

New South Wales , Nicholas Lintzeris , Iain Mcgregor , University Of Sydney Lambert Initiative , Lambert Initiative For Cannabinoid Therapeutics , Therapeutics Goods Administration , Cannabis As Medicine Survey , Senate Inquiry , University Of Sydney , Lambert Initiative , Medicine Survey , Harm Reduction , Professor Nicholas Lintzeris , Professor Iain Mcgregor , Academic Director , Cannabinoid Therapeutics , Addiction Medicine ,

Camurus announces publication showing superior patient treatment satisfaction with Buvidal® weekly and monthly depot injections in opioid dependence

Camurus announces publication showing superior patient treatment satisfaction with Buvidal® weekly and monthly depot injections in opioid dependence
- Randomized, controlled study of Buvidal weekly and monthly subcutaneous depot injections vs daily sublingual buprenorphine
- The primary endpoint was met with statistically higher patient global satisfaction with the depot buprenorphine treatment
- Improved outcomes were also reported for secondary endpoints, including decreased treatment burden and higher quality of life
News provided by
Share this article
LUND, Sweden, May 10, 2021 /PRNewswire/ Camurus (NASDAQ STO: CAMX) announces today the publication in
JAMA Network Open of results from a 24-week, randomized, controlled trial (DEBUT) comparing patient reported outcomes of opioid dependence treatment with subcutaneous weekly and monthly buprenorphine depot injections (Buvidal ....

New South Wales , Fredrik Joabsson , Peter Hjelmstr , Nicholas Lintzeris , Fredrik Tiberg , United Nations , University Of Sydney , Business Development , Depot Evaluation , Utilization Trial , Professor Nicholas Lintzeris , Conjoint Professor , Addiction Medicine , Treatment Satisfaction Questionnaire , Chief Medical Officer , Reported Outcomes , Opioid Dependence , Monthly Subcutaneous Depot , Daily Sublingual Buprenorphine , Randomized Clinical , Product Characteristics , Australian Product , Buvidal Weekly , European Medical Agency , Medical Products , Human Use ,